Wealthspire Advisors (Maryland)’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,618
Closed -$40K 1160
2019
Q1
$40K Buy
1,618
+1,119
+224% +$27.7K ﹤0.01% 971
2018
Q4
$13K Buy
+499
New +$13K ﹤0.01% 1370